173 related articles for article (PubMed ID: 24913521)
1. Genetics: Pinpointing a hotspot in adrenal Cushing syndrome.
Giordano TJ
Nat Rev Endocrinol; 2014 Aug; 10(8):447-8. PubMed ID: 24913521
[No Abstract] [Full Text] [Related]
2. Neuroendocrine cancer. An activating hotspot mutation in PRKACA provides clues for adrenal Cushing syndrome therapeutics.
Sargent J
Nat Rev Endocrinol; 2014 Jun; 10(6):311. PubMed ID: 24751881
[No Abstract] [Full Text] [Related]
3. Medicine. A unified cause for adrenal Cushing's syndrome.
Kirschner LS
Science; 2014 May; 344(6186):804-5. PubMed ID: 24855241
[No Abstract] [Full Text] [Related]
4. Activating hotspot L205R mutation in PRKACA and adrenal Cushing's syndrome.
Cao Y; He M; Gao Z; Peng Y; Li Y; Li L; Zhou W; Li X; Zhong X; Lei Y; Su T; Wang H; Jiang Y; Yang L; Wei W; Yang X; Jiang X; Liu L; He J; Ye J; Wei Q; Li Y; Wang W; Wang J; Ning G
Science; 2014 May; 344(6186):913-7. PubMed ID: 24700472
[TBL] [Abstract][Full Text] [Related]
5. E pluribus unum? The main protein kinase A catalytic subunit (PRKACA), a likely oncogene, and cortisol-producing tumors.
Stratakis CA
J Clin Endocrinol Metab; 2014 Oct; 99(10):3629-33. PubMed ID: 25279575
[No Abstract] [Full Text] [Related]
6. cAMP signaling in cortisol-producing adrenal adenoma.
Calebiro D; Di Dalmazi G; Bathon K; Ronchi CL; Beuschlein F
Eur J Endocrinol; 2015 Oct; 173(4):M99-106. PubMed ID: 26139209
[TBL] [Abstract][Full Text] [Related]
7. Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome.
Beuschlein F; Fassnacht M; Assié G; Calebiro D; Stratakis CA; Osswald A; Ronchi CL; Wieland T; Sbiera S; Faucz FR; Schaak K; Schmittfull A; Schwarzmayr T; Barreau O; Vezzosi D; Rizk-Rabin M; Zabel U; Szarek E; Salpea P; Forlino A; Vetro A; Zuffardi O; Kisker C; Diener S; Meitinger T; Lohse MJ; Reincke M; Bertherat J; Strom TM; Allolio B
N Engl J Med; 2014 Mar; 370(11):1019-28. PubMed ID: 24571724
[TBL] [Abstract][Full Text] [Related]
8. PRKACA mutations in cortisol-producing adenomas and adrenal hyperplasia: a single-center study of 60 cases.
Thiel A; Reis AC; Haase M; Goh G; Schott M; Willenberg HS; Scholl UI
Eur J Endocrinol; 2015 Jun; 172(6):677-85. PubMed ID: 25750087
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase A defects and cortisol-producing adrenal tumors.
Zilbermint M; Stratakis CA
Curr Opin Endocrinol Diabetes Obes; 2015 Jun; 22(3):157-62. PubMed ID: 25871963
[TBL] [Abstract][Full Text] [Related]
10. PKA catalytic subunit mutations in adrenocortical Cushing's adenoma impair association with the regulatory subunit.
Calebiro D; Hannawacker A; Lyga S; Bathon K; Zabel U; Ronchi C; Beuschlein F; Reincke M; Lorenz K; Allolio B; Kisker C; Fassnacht M; Lohse MJ
Nat Commun; 2014 Dec; 5():5680. PubMed ID: 25477193
[TBL] [Abstract][Full Text] [Related]
11. Targeted Mutational Analysis of Cortisol-Producing Adenomas.
Rege J; Hoxie J; Liu CJ; Cash MN; Luther JM; Gellert L; Turcu AF; Else T; Giordano TJ; Udager AM; Rainey WE; Nanba K
J Clin Endocrinol Metab; 2022 Jan; 107(2):e594-e603. PubMed ID: 34534321
[TBL] [Abstract][Full Text] [Related]
12. Alterations in Protein Kinase A Substrate Specificity as a Potential Cause of Cushing Syndrome.
Bathon K; Weigand I; Vanselow JT; Ronchi CL; Sbiera S; Schlosser A; Fassnacht M; Calebiro D
Endocrinology; 2019 Feb; 160(2):447-459. PubMed ID: 30615103
[TBL] [Abstract][Full Text] [Related]
13. Recurrent somatic mutations underlie corticotropin-independent Cushing's syndrome.
Sato Y; Maekawa S; Ishii R; Sanada M; Morikawa T; Shiraishi Y; Yoshida K; Nagata Y; Sato-Otsubo A; Yoshizato T; Suzuki H; Shiozawa Y; Kataoka K; Kon A; Aoki K; Chiba K; Tanaka H; Kume H; Miyano S; Fukayama M; Nureki O; Homma Y; Ogawa S
Science; 2014 May; 344(6186):917-20. PubMed ID: 24855271
[TBL] [Abstract][Full Text] [Related]
14. Double adrenocortical adenomas harboring independent KCNJ5 and PRKACA somatic mutations.
Nanba K; Omata K; Tomlins SA; Giordano TJ; Hammer GD; Rainey WE; Else T
Eur J Endocrinol; 2016 Aug; 175(2):K1-6. PubMed ID: 27165862
[TBL] [Abstract][Full Text] [Related]
15. Novel somatic mutations in the catalytic subunit of the protein kinase A as a cause of adrenal Cushing's syndrome: a European multicentric study.
Di Dalmazi G; Kisker C; Calebiro D; Mannelli M; Canu L; Arnaldi G; Quinkler M; Rayes N; Tabarin A; Laure Jullié M; Mantero F; Rubin B; Waldmann J; Bartsch DK; Pasquali R; Lohse M; Allolio B; Fassnacht M; Beuschlein F; Reincke M
J Clin Endocrinol Metab; 2014 Oct; 99(10):E2093-100. PubMed ID: 25057884
[TBL] [Abstract][Full Text] [Related]
16. Abnormalities of cAMP signaling are present in adrenocortical lesions associated with ACTH-independent Cushing syndrome despite the absence of mutations in known genes.
Bimpaki EI; Nesterova M; Stratakis CA
Eur J Endocrinol; 2009 Jul; 161(1):153-61. PubMed ID: 19429701
[TBL] [Abstract][Full Text] [Related]
17. Somatic mutations of the catalytic subunit of cyclic AMP-dependent protein kinase (PRKACA) gene in Japanese patients with several adrenal adenomas secreting cortisol [Rapid Communication].
Nakajima Y; Okamura T; Gohko T; Satoh T; Hashimoto K; Shibusawa N; Ozawa A; Ishii S; Tomaru T; Horiguchi K; Okada S; Takata D; Rokutanda N; Horiguchi J; Tsushima Y; Oyama T; Takeyoshi I; Yamada M
Endocr J; 2014; 61(8):825-32. PubMed ID: 25069672
[TBL] [Abstract][Full Text] [Related]
18. Molecular Genetic and Genomic Alterations in Cushing's Syndrome and Primary Aldosteronism.
Kamilaris CDC; Stratakis CA; Hannah-Shmouni F
Front Endocrinol (Lausanne); 2021; 12():632543. PubMed ID: 33776926
[TBL] [Abstract][Full Text] [Related]
19. Genetics of adrenocortical tumors: gatekeepers, landscapers and conductors in symphony.
Stratakis CA
Trends Endocrinol Metab; 2003 Nov; 14(9):404-10. PubMed ID: 14580759
[TBL] [Abstract][Full Text] [Related]
20. Animal models of adrenocortical tumorigenesis.
Galac S; Wilson DB
Endocrinol Metab Clin North Am; 2015 Jun; 44(2):297-310. PubMed ID: 26038202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
